FDA announces voluntary inhaler recall

NCPA September 22, 2020

The FDA announced a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo Pharmaceutical Co. in Minneapolis, due to possible clogging of the inhaler, resulting in patients not receiving enough or any medicine. This recall is to the retail level. FDA urges patients to continue using the inhaler they have on hand. Details here.

NCPA